OpenTrons has raised $241 million across multiple rounds, including a $200 million Series C round in September 2021, led by SoftBank Vision Fund, which brought its valuation to $1.8 billion. Earlier funding included a $20.6 million Series B (2020) and seed rounds backed by Y Combinator, SOSV, and Khosla Ventures. Founded in 2013 and headquartered in Brooklyn, New York, Opentrons develops automated pipetting robots like the OT-2 and Flex. The funding supports global expansion, enhances lab automation capabilities, and facilitates the development of next-generation robotic tools for scientific research.